Preventive Vaccines Market Size Trends, Analysis, and Forecast till 2035

Published Aug 01, 2023

Length 165 Pages

SKU # PRMI20292787

Description

The Preventive Vaccines Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.

Preventive vaccines aim to enhance the immune system's ability to combat infections before they cause illness. The preventive vaccines market growth is driven by their importance, cost-effectiveness, and potential to reduce antibiotic resistance. Factors contributing to market expansion include increasing infectious diseases, geriatric populations, government immunization programs, technological advancements, research funding, emerging diseases, cold chain infrastructure expansion, and combination vaccine adoption. Strong partnerships between pharma companies, governments, and non-profits further drive this growth.

Report Highlights:

Preventive vaccines market size is accounted at USD 91.6 Billion in 2025.

Target market size is expected to develop at a rate of USD 112.2 Billion by 2035 and at a CAGR of 2.2%.

On the basis of vaccine type, the conjugate vaccines segment is attributed to dominate the preventive vaccines market share.

Stemming from disease type, the pneumococcal segment is holding the upper hand in the preventive vaccines market growth.

Based on distribution channel, the public segment is expected to lead the preventive vaccines market size.

By geography, North America is ruling over the preventive vaccines market share.

Europe is the region which has the fastest growing preventive vaccines market, during the forecast period.

Key Highlights:

In June 2024, Gavi, the Vaccine Alliance announced that the lower-income countries it supports could apply to introduce four additional vaccines: preventive Ebola, human rabies vaccine for post-exposure prophylaxis, multivalent meningococcal conjugate and hepatitis B birth dose. These four vaccine programmes were previously approved by the Gavi Board but put on hold either due to the COVID-19 pandemic (in the case of human rabies for post-exposure prophylaxis and hepatitis B birth dose); pending availability of suitable products (multivalent meningococcal conjugate); or appropriate policy recommendations (preventive Ebola)..

Report Analysis:

Characteristics of Reconstruction Plate of Veterinary Orthopedic Implants:

The US Food and Drug Administration (FDA) has approved the vaccine (immunization).
The vaccine (immunization) is subject to explicit ACIP recommendations (e.g., should, shall, is), and not permissive recommendations, for routine use as published in the Morbidity & Mortality Weekly Report (MMWR) of the Centers for Disease Control and Prevention (CDC).
The vaccine (immunization) is listed on the applicable immunization schedule of ACIP.
The vaccine (immunization) is not otherwise excluded by the plan as explained in the member specific benefit plan document.

Segmentation:

By Vaccine Type:

Live/Attenuated Vaccine
Inactivated Vaccine
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vector Vaccines
DNA Vaccines

By Disease Type:

Pneumococcal
Poliovirus
Hepatitis
Influenza
Measles, Mumps and Rubella (MMR)
Varicella
Human Papilloma Virus
Others

By Distribution Channel:

Public
Private

By Region:

North America
U.S.
Canada
Europe
Germany
U.K.
France
Russia
Italy
Spain
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East & Africa
GCC
Israel
South Africa
Rest of Middle East & Africa

Preventive Vaccines Market Companies:

Moderna, Inc.

Merck & Co., Inc.

Pfizer Inc.

GSK plc.

Sanofi

AstraZeneca

Bharat Biotech

Valneva SE

Minervax

VBI Vaccines Inc.

GSBPL

Serum Institute of India Pvt. Ltd.

CSL

SINOVAC

Johnson & Johnson Services, Inc.

What You’ll Gain from This Report:

Regional & Country-Specific Insights: Unlock detailed market share analysis across key regions and countries, empowering you to pinpoint growth opportunities and optimize your strategic positioning.
Guidance for Market Entry: Expert-backed strategies to overcome entry barriers, establish a foothold, and accelerate expansion in new or competitive markets.
Reliable Long-Term Forecasts: Data-driven projections from 2025 to 2035, including pivotal milestones for 2025, 2026, and 2030, ensuring confident, future-proof investments.
In-Depth Market Trend Analysis: Explore the forces shaping the industry—drivers, challenges, emerging opportunities, and risks—along with insights into high-growth sectors and potential obstacles.
Proven Business Strategies: Actionable, data-backed recommendations tailored to key market segments, helping you maximize profitability and outperform competitors.
Competitive Intelligence: Stay ahead with a clear view of industry trends, competitor strategies, and untapped market potential to refine your approach.
Exclusive Company Profiles: In-depth analysis of top market players, including business models, financial performance, strategic initiatives, and recent developments.
Innovative Supply Chain Trends: Discover the latest technological advancements transforming supply chains—boosting efficiency, cutting costs, and driving innovation.

This report provides the strategic intelligence you need to navigate a dynamic market landscape and make decisions that propel long-term success.

FAQs:

Key Questions Answered in the Report.

1. What was the Preventive Vaccines Market size in 2025?

2. What is projected growth rate of the Preventive Vaccines Market during 2025-2035?

3. What are the key factors driving the Preventive Vaccines Market growth?

4. What are leading players in the Preventive Vaccines Market?

5. What are the key regions analyzed in the Preventive Vaccines Market?

6. Which region is dominating in the Preventive Vaccines Market?

Research Objective and Assumption: Research Objectives; Assumptions; Abbreviations; Market Preview
Report Description: Market Definition and Scope; Executive Summary; Market Snippet, By Vaccine Type; Market Snippet, By Disease Type; Market Snippet, By Distribution Channel; Market Snippet, By Region; Opportunity Map Analysis; Market Dynamics, Regulations, and Trends Analysis; Market Dynamics; Drivers; Restraints; Market Opportunities; Market Trends; Product Launch; Merger and Acquisitions; Impact Analysis; PEST Analysis; Porter’s Analysis; Vaccine Schedules and Administration; Combination and Co-Administration of Vaccines; Development of Advanced Vaccines; Market Segmentation, By Vaccine Type, Forecast Period up to 10 Years, (USD Bn)
Overview: Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years; Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years; Segment Trends; Live/Attenuated Vaccine
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Inactivated Vaccine
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Subunit Vaccines
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Toxoid Vaccines
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Conjugate Vaccines
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Recombinant Vector Vaccines
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; DNA Vaccines
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Market Segmentation, By Disease Type, Forecast Period up to 10 Years, (USD Bn)
Overview: Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years; Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years; Segment Trends; Pneumococcal
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Poliovirus
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Hepatitis
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Influenza
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Measles Mumps and Rubella (MMR)
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Varicella
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Human Papilloma Virus
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Others
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Market Segmentation, By Distribution Channel, Forecast Period up to 10 Years, (USD Bn)
Overview: Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years; Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years; Segment Trends; Public
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Private
Overview: Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years; Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
Overview: Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years; Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years; Regional Trends; North America; Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Disease Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years; U.S.; Canada; Asia Pacific; Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Disease Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years; China; India; Japan; Australia; Indonesia; Malaysia; South Korea; Rest of Asia Pacific; Europe; Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Disease Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years; Germany; U.K.; France; Russia; Italy; Spain; Netherlands; Rest of Europe; Latin America; Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Disease Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years; Brazil; Mexico; Argentina; Rest of Latin America; Middle East and Africa; Market Size and Forecast (USD Bn), By Vaccine Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Disease Type, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Distribution Channel, Forecast Period up to 10 Years; Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years; GCC; Israel; South Africa; Rest of Middle East & Africa

Pricing

Currency Rates

Single User Email from Publisher $3,450
Global Site License Email from Publisher $5,450

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now